These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
456 related items for PubMed ID: 28160549
1. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification. Chinea FM, Lyapichev K, Epstein JI, Kwon D, Smith PT, Pollack A, Cote RJ, Kryvenko ON. Oncotarget; 2017 Mar 28; 8(13):20802-20812. PubMed ID: 28160549 [Abstract] [Full Text] [Related]
2. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen. Fuletra JG, Kamenko A, Ramsey F, Eun DD, Reese AC. Can J Urol; 2018 Feb 28; 25(1):9193-9198. PubMed ID: 29524974 [Abstract] [Full Text] [Related]
6. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA. Lediju O, Ikuemonisan J, Salami SS, Adejoro O. J Racial Ethn Health Disparities; 2019 Apr 28; 6(2):401-408. PubMed ID: 30506310 [Abstract] [Full Text] [Related]
9. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. Eastham JA, Kattan MW. J Urol; 2000 Jan 28; 163(1):143-5. PubMed ID: 10604332 [Abstract] [Full Text] [Related]
11. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL. BJU Int; 2012 Jul 28; 110(1):36-42. PubMed ID: 22085203 [Abstract] [Full Text] [Related]
13. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer. Hayn MH, Orom H, Shavers VL, Sanda MG, Glasgow M, Mohler JL, Underwood W. Cancer; 2011 Oct 15; 117(20):4651-8. PubMed ID: 21456009 [Abstract] [Full Text] [Related]
18. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance. Nelson TJ, Javier-DesLoges J, Deka R, Courtney PT, Nalawade V, Mell L, Murphy J, Parsons JK, Rose BS. JAMA Netw Open; 2021 May 03; 4(5):e219452. PubMed ID: 33999164 [Abstract] [Full Text] [Related]